2-oxo-heterocyclic compounds and the pharmaceutical...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S183000, C548S530000, C548S400000

Reexamination Certificate

active

07846963

ABSTRACT:
The present invention is related to new 2-oxo-cyclic compound the process for preparing them and a pharmaceutical composition comprising the same. The present invention provides a pharmaceutical composition for preventing and treating the inflammatory disease comprising the pain or inflammation caused by rheumatic disease, for example, rheumatoid arthritis, spondyloarthopathies, gout, osteoarthritis, systemic lupus erythematosus and juvenile arthritis, and inflammatory syndrome for example, from myositis, gingivitis, synovitis, ankylosing spondylitis, burstitis, burns and scar, inflammatory Crohn's disease, Types I diabetes. therefore, it can be used as the therapeutics for treating and preventing inflammatory diseases.

REFERENCES:
patent: 5281585 (1994-01-01), Duggan
patent: 6110930 (2000-08-01), Taniguchi
patent: 6303613 (2001-10-01), McInally
patent: 6476023 (2002-11-01), Cirillo
patent: 870763 (1998-10-01), None
patent: 2268934 (1994-01-01), None
patent: 1042640 (1996-09-01), None
patent: PCT/GB89/01398 (1990-05-01), None
patent: PCT/GB92/00230 (1992-08-01), None
patent: PCT/US92/03809 (1992-10-01), None
patent: PCT/GB93/01556 (1994-03-01), None
patent: PCT/GB94/00808 (1994-10-01), None
patent: PCT/GB94/02145 (1995-04-01), None
patent: PCT/US97/00523 (1997-09-01), None
patent: WO 97/32846 (1997-09-01), None
patent: 97/36900 (1997-10-01), None
patent: 98/45294 (1998-10-01), None
J. Bone Joint Surg . 52A , pp. 424-434, 1970.
Clin. Exp. Immunol. 81 , p. 301, 1990.
Nature, 370 , p. 555, 1994.
Journal of Organic Chemistry, 1996, vol. 61, No. 7, pp. 2283-2292.
Canadian Journal of Chemistry, 1983, vol. 61, No. 9, pp. 2016-2021.
Tetrahedron Letters (1995), (No. 5), 4-9.
Lee, D. et al., alpha-Methylenelactam rearrangement, 1974, J. Org. Chem., vol. 39, No. 7, 893-902.
Hirata, T. et al., 1959, The structure of Cypridina Luciferin, Tetrahedron Letters, No. 5, pp. 4-9.
EP Search Report, Feb. 4, 2009.
Supplementary EP Search Report, Jul. 3, 2008.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-oxo-heterocyclic compounds and the pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-oxo-heterocyclic compounds and the pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-oxo-heterocyclic compounds and the pharmaceutical... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4176852

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.